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Recently, birth of premature babies and low birth weight babies has been increasing 
and survival rate of very low birth weight babies even under 500 g not to mention under 
1,000 g is remarkably enhanced thanks to the development of neonatology. With the 
enhanced birth rate and survival rate, the issue of pediatrics majoring in neonatology 
is not increasing survival rate anymore but making them healthier babies. While 
treating premature babies in the field, it is found that some premature babies have better 
prognoses while others have poor prognoses.
As a part of efforts to identify the factors influencing prognoses of newborns, studies 
on prenatal infections are actively made. One of the hottest topics is Ureaplasma infection. 
Although it has been studied before, it has been perceived as ‘sexually-transmitted 
disease’ and has been studied in gynecology or urology. Recently, however, it is expanded 
to the field of complications of premature babies
1,2). Additionally, studies have been 
actively performed since strain known as Ureaplamsa urealyticum was segmented to 
Ureaplasma parvum (UPA hereunder) and Ureaplasma urealyticum (UUR hereunder), 
which were further segmented to 14 serovars
2,3). 
Past studies published before in Korea by Lim et al.
4) and by Chang et al.
5) were studies 
on overall prevalence before Ureaplasma colonization was segmented into two serovars. 
In this point, Eun et al.
6) is encouraging because it studied serovars of Korean premature 
babies. 
However, it has limitations at the same time. Although it is meaningful that it tried to 
analyze premature babies according to serovar, it dealt with UUR only and the conclusion 
that there would be no difference between Ureaplasma serovars may be misleading. As 
authors mentioned before, Ureaplasma spp is segmented to two biovars such as UPA and 
UUR. Such two biovars can be segmented according to genome size, 16S rRNA gene 
sequences, the 16S-23S rRNA intergenic region, enzyme polymorphisms, DNA-DNA 
hybridization, differential growth responses to manganese, and differences in the multiple 
banded antigen (mba) genes
2,3). They are segmented to 14 serovars by polymerase chain 
reaction (PCR)-based methods based on the previously mentioned UPA (biovar 1, serovar 
3, ATCC* 27815, NCTC** 11736), and UUA (biovar 2, serovar 8, ATCC* 27618, NCTC** 
10177). According to characteristics of each serovar, serovar 1, 3, 6, and 14 fall under 
biovar 1, so to speak UPA, and rest of them fall under biovar 2, so to speak UUR. On the 
other hand strains that have not been clear in classification are more segmented and 5 
more strains have been discovered
7) (Table 1). 
Accordingly, authors should discuss the difference between UPA and UUR serovars first 
to claim that there was no difference in bronchopulmonary dysplasia (BPD) incidence 
in each servoar. It seems misleading that they say there was no difference according 
to BPD and serovars because their study had very limited subjects and approximately 
1/3 had mixed serovars. Additionally, some investigators consider these mixed strains 475 http://dx.doi.org/10.3345/kjp.2013.56.11.474
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as totally different serovars according to hybridization and 
wonder if studies investigating difference among serovars are 
meaningless
8). Although it is one of major conclusions of Eun 
and et al.
6) that there is no difference between UUR serovars, 
the conclusion is not well established and it is better to get to a 
conclusion after experiments using UPA and UUR together.
Ureaplasma is known as a strain difficult to culture in the 
laboratory because it is very small such as 15–25 micrometer 
diameter and has no cell wall. This strain produces adenosine 
triphosphate through urea hydrolysis and dissolves urea into 
ammonia (NH3) and carbon gas. When culturing in the labo-
ratory, infection is judged through pH change in liquid culture 
using such principle. But recently, as studies have shown that 
PCR method is more sensitive, PCR method is preferred to 
classical culture
1-3). To make more explanations on culture and 
PCR method, authors perform tracheal aspiration and gastric 
aspiration at the same time to identify correlations with BPD. 
As tracheal aspiration samples show whether there is lower 
respiratory colonization, which means infection in most cases, 
and may judge infection of Ureaplasma spp regardless of skills 
of testers, it is the most preferred method. However, it has a 
drawback that sampling can be made in newborns only with 
intubation. A probable alternative is nasopharyngeal swab. It is 
easy to get samples and can be repeated many times, although 
some authors said that we cannot judge infection only with the 
result of this test showing upper respiratory colonization
1,2). 
Interestingly, in Eun et al.
6) study, UUR serovar 9 is found to 
be the most common serovar, which was deal with Koreans. 
Whereas Sung et al.
9) studies on Caucasians and African-
Americans found that serovar 11 was the most common. Such 
difference may imply difference between races, although it must 
be confirmed with further studies, because of small sample size 
of this study. In particular, as there have not been many studies 
regarding the difference between races, it will be an interesting 
field to perform a large-scale study including gene tests. 
Many studies on relationship between Ureaplasma spp and 
complications of premature babies have been made recently and 
results are being published constantly. Among them, mechanism 
to make BPD by Ureaplasma spp. is considered as being made 
by activation of proinflammatory cytokines (tumor necrosis 
factor-α, interleukin [IL] 1β, IL-8) or blocking counterregulatory 
cytokines (IL-6, IL-10) rather than making direct damages on 
respiratory tract. There is a hypothesis that respiratory diseases 
and BPD of newborns are caused by phospholipase A2 created 
by other strains which coerces the creation of pulmonary 
surface activators. It is also know that infection in prenatal 
period stimulates infection consecutive infection of pulmonary 
alveoli, interferes the creation of pulmonary alveoli by directly 
or indirectly influencing respirator induced pulmonary damages, 
stimulates phagocytes composing cilliary disarray and clumping 
after composing colony on epithelial cells on respiratory tracts, 
and creates proinflammatory cytokine to cause BPD
1,10,11). Such 
Table 1. Overview of Ureaplasma urealyticum and Ureaplasma parvum genomes
Serovar ATCC GenBankaccession PFGE size (kbp) Genome size (bp) Contigs ORFs Hypothetical proteins % GC Sequence coverage
1 27813 NZ_ABES00000000 760 753,674 8 604 212 25% 14.6X
3 27815 NC_010503 760 751,679 1 609 219 25% 10.2X
3 700970 NC_002162 Patient  isolate 751,719 1 614 154 25% -
6 27818 NZ_AAZQ00000000 760 772,971 5 619 221 25% 11.4X
14 33697 NZ_ABER00000000 760 749,965 7 594 199 25% 14.5X
2 27814 NZ_ABFL00000000 880 861,061 1 664 248 26% 10.7X
4 27816 NZ_AAYO00000000 910 835,413 4 654 206 26% 7.0X
5 27817 NZ_AAZR00000000 1140 884,046 18 677 252 26% 8.5X
7 27819 NZ_AAYP00000000 880 875,530 4 660 246 26% 8.3X
8 27618 NZ_AAYN00000000 890 874,381 1 673 232 26% 9.9X
9 33175 NZ_AAYQ00000000 950 947,165 10 711 244 26% 8.6X
10 33699 NC_011374 890 874,478 1 657 232 26% 12.1X
11 33695 NZ_AAZS00000000 840 876,474 6 644 236 27% 10.0X
12 33696 NZ_AAZT00000000 870 873,466 2 650 234 25% 9.0X
13 33698 NZ_ABEV00000000 900 846,596 5 655 234 25% 11.1X
2033 Unknown serovar AJFX00000000 Patient  isolate 804,560 16 646 190 26% 39.0X
2608 Unknown serovar AJFY00000000 Patient  isolate 856,546 14 667 258 26% 60.0X
4155 Unknown serovar AJFZ00000000 Patient  isolate 858,890 18 684 225 26% 73.0X
4318 Unknown serovar AJGA00000000 Patient  isolate 844,630 16 662 214 26% 52.0X
PFGE, pulsed-field Gel Electrophoresis; ORF, open-reading frame; GC, guanine-cytosine.http://dx.doi.org/10.3345/kjp.2013.56.11.474
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relationship with cytokines should be studied further in the 
future. 
 Conclusively, more studies are needed on the relationship 
between Ureaplasam and infection of newborns, in particular 
complications of premature babies including BPD. It is also 
needed to perform a large scale study on Korean newborns. 
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